A citation-based method for searching scientific literature

Deepak L Bhatt, Michael Szarek, Bertram Pitt, Christopher P Cannon, Lawrence A Leiter, Darren K McGuire, Julia B Lewis, Matthew C Riddle, Silvio E Inzucchi, Mikhail N Kosiborod, David Z I Cherney, Jamie P Dwyer, Benjamin M Scirica, Clifford J Bailey, Rafael Díaz, Kausik K Ray, Jacob A Udell, Renato D Lopes, Pablo Lapuerta, P Gabriel Steg. N Engl J Med 2021
Times Cited: 7







List of co-cited articles
18 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.
Deepak L Bhatt, Michael Szarek, P Gabriel Steg, Christopher P Cannon, Lawrence A Leiter, Darren K McGuire, Julia B Lewis, Matthew C Riddle, Adriaan A Voors, Marco Metra,[...]. N Engl J Med 2021
13
85

Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes.
Christopher P Cannon, Richard Pratley, Samuel Dagogo-Jack, James Mancuso, Susan Huyck, Urszula Masiukiewicz, Bernard Charbonnel, Robert Frederich, Silvina Gallo, Francesco Cosentino,[...]. N Engl J Med 2020
38
71

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
57

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Milton Packer, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Stuart J Pocock, Peter Carson, James Januzzi, Subodh Verma, Hiroyuki Tsutsui, Martina Brueckmann,[...]. N Engl J Med 2020
128
57

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
57

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
42

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
964
42

Dapagliflozin in Patients with Chronic Kidney Disease.
Hiddo J L Heerspink, Bergur V Stefánsson, Ricardo Correa-Rotter, Glenn M Chertow, Tom Greene, Fan-Fan Hou, Johannes F E Mann, John J V McMurray, Magnus Lindberg, Peter Rossing,[...]. N Engl J Med 2020
79
42

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
753
42

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes.
Mark C Petrie, Subodh Verma, Kieran F Docherty, Silvio E Inzucchi, Inder Anand, Jan Belohlávek, Michael Böhm, Chern-En Chiang, Vijay K Chopra, Rudolf A de Boer,[...]. JAMA 2020
43
28

Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF.
Felipe A Martinez, Matteo Serenelli, Jose C Nicolau, Mark C Petrie, Chern-En Chiang, Sergey Tereshchenko, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod,[...]. Circulation 2020
33
28

Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
28

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
Adrian F Hernandez, Jennifer B Green, Salim Janmohamed, Ralph B D'Agostino, Christopher B Granger, Nigel P Jones, Lawrence A Leiter, Anne E Rosenberg, Kristina N Sigmon, Matthew C Somerville,[...]. Lancet 2018
445
28

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
Marc A Pfeffer, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Hertzel C Gerstein, Lars V Køber, Francesca C Lawson, Lin Ping, Xiaodan Wei, Eldrin F Lewis,[...]. N Engl J Med 2015
28

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
28

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Mansoor Husain, Andreas L Birkenfeld, Morten Donsmark, Kathleen Dungan, Freddy G Eliaschewitz, Denise R Franco, Ole K Jeppesen, Ildiko Lingvay, Ofri Mosenzon, Sue D Pedersen,[...]. N Engl J Med 2019
246
28

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
Rury R Holman, M Angelyn Bethel, Robert J Mentz, Vivian P Thompson, Yuliya Lokhnygina, John B Buse, Juliana C Chan, Jasmine Choi, Stephanie M Gustavson, Nayyar Iqbal,[...]. N Engl J Med 2017
656
28

Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial.
Michael E Nassif, Sheryl L Windsor, Fengming Tang, Yevgeniy Khariton, Mansoor Husain, Silvio E Inzucchi, Darren K McGuire, Bertram Pitt, Benjamin M Scirica, Bethany Austin,[...]. Circulation 2019
67
28

Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis.
Allan L Klein, Massimo Imazio, Paul Cremer, Antonio Brucato, Antonio Abbate, Fang Fang, Antonella Insalaco, Martin LeWinter, Basil S Lewis, David Lin,[...]. N Engl J Med 2021
3
33

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
George L Bakris, Rajiv Agarwal, Stefan D Anker, Bertram Pitt, Luis M Ruilope, Peter Rossing, Peter Kolkhof, Christina Nowack, Patrick Schloemer, Amer Joseph,[...]. N Engl J Med 2020
16
14

Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA.
S Claiborne Johnston, Pierre Amarenco, Hans Denison, Scott R Evans, Anders Himmelmann, Stefan James, Mikael Knutsson, Per Ladenvall, Carlos A Molina, Yongjun Wang. N Engl J Med 2020
18
14

Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives.
Chiara Maria Assunta Cefalo, Francesca Cinti, Simona Moffa, Flavia Impronta, Gian Pio Sorice, Teresa Mezza, Alfredo Pontecorvi, Andrea Giaccari. Cardiovasc Diabetol 2019
26
14

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. Reply.
John J V McMurray, Kieran F Docherty, Pardeep S Jhund. N Engl J Med 2020
8
14

Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update.
Husam M Salah, Subhi J Al'Aref, Muhammad Shahzeb Khan, Malek Al-Hawwas, Srikanth Vallurupalli, Jawahar L Mehta, J Paul Mounsey, Stephen J Greene, Darren K McGuire, Renato D Lopes,[...]. Am Heart J 2020
1
100

Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction.
Kieran F Docherty, Li Shen, Davide Castagno, Mark C Petrie, William T Abraham, Michael Böhm, Akshay S Desai, Kenneth Dickstein, Lars V Køber, Milton Packer,[...]. Eur J Heart Fail 2020
5
20

Comparing the Benefit of Novel Therapies Across Clinical Trials: Insights From the VICTORIA Trial.
Javed Butler, Kevin J Anstrom, Paul W Armstrong. Circulation 2020
12
14

The impact of COVID-19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic.
Daniel I Bromage, Antonio Cannatà, Irfan A Rind, Caterina Gregorio, Susan Piper, Ajay M Shah, Theresa A McDonagh. Eur J Heart Fail 2020
30
14

Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial.
Milton Packer, Stefan D Anker, Javed Butler, Gerasimos Filippatos, João Pedro Ferreira, Stuart J Pocock, Peter Carson, Inder Anand, Wolfram Doehner, Markus Haass,[...]. Circulation 2021
2
50

Coronary microcirculation and hypertensive heart failure.
Javier Escaned, Lilach O Lerman. Eur Heart J 2020
3
33

Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis.
Lili Zhang, Magid Awadalla, Syed S Mahmood, Anju Nohria, Malek Z O Hassan, Franck Thuny, Daniel A Zlotoff, Sean P Murphy, James R Stone, Doll Lauren Alexandra Golden,[...]. Eur Heart J 2020
23
14

N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes: Vericiguat Heart Failure With Reduced Ejection Fraction Study.
Justin A Ezekowitz, Christopher M O'Connor, Richard W Troughton, Wendimagegn G Alemayehu, Cynthia M Westerhout, Adriaan A Voors, Javed Butler, Carolyn S P Lam, Piotr Ponikowski, Michele Emdin,[...]. JACC Heart Fail 2020
3
33

Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study.
Francisco J de Abajo, Sara Rodríguez-Martín, Victoria Lerma, Gina Mejía-Abril, Mónica Aguilar, Amelia García-Luque, Leonor Laredo, Olga Laosa, Gustavo A Centeno-Soto, Maria Ángeles Gálvez,[...]. Lancet 2020
138
14


Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.
Iacopo Olivotto, Artur Oreziak, Roberto Barriales-Villa, Theodore P Abraham, Ahmad Masri, Pablo Garcia-Pavia, Sara Saberi, Neal K Lakdawala, Matthew T Wheeler, Anjali Owens,[...]. Lancet 2020
22
14

Improve Management of acute heart failure with ProcAlCiTonin in EUrope: results of the randomized clinical trial IMPACT EU Biomarkers in Cardiology (BIC) 18.
Martin Möckel, Rudolf A de Boer, Anna Christine Slagman, Stephan von Haehling, Morten Schou, Jörn Ole Vollert, Jan C Wiemer, Stefan Ebmeyer, F Javier Martín-Sánchez, Alan S Maisel,[...]. Eur J Heart Fail 2020
4
25

Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19.
Harmony R Reynolds, Samrachana Adhikari, Claudia Pulgarin, Andrea B Troxel, Eduardo Iturrate, Stephen B Johnson, Anaïs Hausvater, Jonathan D Newman, Jeffrey S Berger, Sripal Bangalore,[...]. N Engl J Med 2020
396
14

Cost-effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health-economic analysis of DAPA-HF.
Phil McEwan, Oliver Darlington, John J V McMurray, Pardeep S Jhund, Kieran F Docherty, Michael Böhm, Mark C Petrie, Klas Bergenheim, Lei Qin. Eur J Heart Fail 2020
7
14

Atrial fibrillation in acute heart failure: A position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology.
Bulent Gorenek, Sigrun Halvorsen, Gulmira Kudaiberdieva, Hector Bueno, Isabelle C Van Gelder, Maddalena Lettino, Francisco Marin, Josep Masip, Christian Mueller, Sercan Okutucu,[...]. Eur Heart J Acute Cardiovasc Care 2020
4
25

Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
Michael R Zile, JoAnn Lindenfeld, Fred A Weaver, Faiez Zannad, Elizabeth Galle, Tyson Rogers, William T Abraham. J Am Coll Cardiol 2020
6
16

CMR in the Evaluation of Diastolic Dysfunction and Phenotyping of HFpEF: Current Role and Future Perspectives.
Mohammed A Chamsi-Pasha, Yang Zhan, Dany Debs, Dipan J Shah. JACC Cardiovasc Imaging 2020
9
14

Aetiology and outcomes of severe right ventricular dysfunction.
Ratnasari Padang, Nikhitha Chandrashekar, Manasawee Indrabhinduwat, Christopher G Scott, Sushil A Luis, Krishnaswamy Chandrasekaran, Hector I Michelena, Vuyisile T Nkomo, Sorin V Pislaru, Patricia A Pellikka,[...]. Eur Heart J 2020
10
14

Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19.
Giuseppe Mancia, Federico Rea, Monica Ludergnani, Giovanni Apolone, Giovanni Corrao. N Engl J Med 2020
407
14

Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.
Johann Bauersachs, Tobias König, Peter van der Meer, Mark C Petrie, Denise Hilfiker-Kleiner, Amam Mbakwem, Righab Hamdan, Alice M Jackson, Paul Forsyth, Rudolf A de Boer,[...]. Eur J Heart Fail 2019
43
14

Incremental prognostic value of a novel metabolite-based biomarker score in congestive heart failure patients.
Peter McGranaghan, Hans-Dirk Düngen, Anshul Saxena, Muni Rubens, Joseph Salami, Jasmin Radenkovic, Doris Bach, Svetlana Apostolovic, Goran Loncar, Marija Zdravkovic,[...]. ESC Heart Fail 2020
2
50

Telemonitoring versus standard care in heart failure: a randomised multicentre trial.
Michel Galinier, François Roubille, Philippe Berdague, Gilles Brierre, Philippe Cantie, Patrick Dary, Jean-Marc Ferradou, Olivier Fondard, Jean Philippe Labarre, Jacques Mansourati,[...]. Eur J Heart Fail 2020
4
25

Peripartum Cardiomyopathy: JACC State-of-the-Art Review.
Melinda B Davis, Zolt Arany, Dennis M McNamara, Sorel Goland, Uri Elkayam. J Am Coll Cardiol 2020
13
14

Treatment with 24 hour istaroxime infusion in patients hospitalised for acute heart failure: a randomised, placebo-controlled trial.
Valentina Carubelli, Yuhui Zhang, Marco Metra, Carlo Lombardi, G Michael Felker, Gerasimos Filippatos, Christopher M O'Connor, John R Teerlink, Phillip Simmons, Robert Segal,[...]. Eur J Heart Fail 2020
5
20

Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
Stefan D Anker, Javed Butler, Muhammad Shahzeb Khan, William T Abraham, Johann Bauersachs, Edimar Bocchi, Biykem Bozkurt, Eugene Braunwald, Vijay K Chopra, John G Cleland,[...]. Eur Heart J 2020
13
14

Palliative care for people living with heart failure: European Association for Palliative Care Task Force expert position statement.
Piotr Z Sobanski, Bernd Alt-Epping, David C Currow, Sarah J Goodlin, Tomasz Grodzicki, Karen Hogg, Daisy J A Janssen, Miriam J Johnson, Małgorzata Krajnik, Carlo Leget,[...]. Cardiovasc Res 2020
19
14

Temporal Trends in Prevalence and Prognostic Implications of Comorbidities Among Patients With Acute Decompensated Heart Failure: The ARIC Study Community Surveillance.
Ambarish Pandey, Muthiah Vaduganathan, Sameer Arora, Arman Qamar, Robert J Mentz, Sanjiv J Shah, Patricia P Chang, Stuart D Russell, Wayne D Rosamond, Melissa C Caughey. Circulation 2020
5
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.